β Home
βΉοΈ Info
π§Ύ Overview π Core Facts π₯ Video Blog β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π’ Company Q&A π οΈ Industry Q&A π Competitors π Stock Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risks π§© Segmentationπ§ Tools
β Due DiligenceBalance Sheet
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Cash And Cash Equivalents | Short Term Investments | Cash And Short Term Investments | Net Receivables | Inventory | Other Current Assets | Total Current Assets | Property Plant Equipment Net | Goodwill | Intangible Assets | Goodwill And Intangible Assets | Long Term Investments | Tax Assets | Other Non Current Assets | Total Non Current Assets | Other Assets | Total Assets | Account Payables | Short Term Debt | Tax Payables | Deferred Revenue | Other Current Liabilities | Total Current Liabilities | Long Term Debt | Deferred Revenue Non Current | Deferred Tax Liabilities Non Current | Other Non Current Liabilities | Total Non Current Liabilities | Other Liabilities | Capital Lease Obligations | Total Liabilities | Preferred Stock | Common Stock | Retained Earnings | Accumulated Other Comprehensive Income Loss | Other Total Stockholders Equity | Total Stockholders Equity | Total Equity | Total Liabilities And Stockholders Equity | Minority Interest | Total Liabilities And Total Equity | Total Investments | Total Debt | Net Debt |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09 | 4585.0 | 0.0 | 4585.0 | 0.0 | 18005.0 | 19769.0 | 42468.0 | 20911.0 | 88.0 | 12356.0 | 12444.0 | 0.0 | 1139.0 | 13035.0 | 47529.0 | 3.0 | 90000.0 | 4140.0 | 22969.0 | 1567.0 | 0.0 | 7121.0 | 35797.0 | 6285.0 | 0.0 | 0.0 | 2357.0 | 8642.0 | 0.0 | 5271.0 | 44439.0 | 0.0 | 3799.0 | 34256.0 | 0.0 | 7503.0 | 45558.0 | 45561.0 | 90000.0 | 3.0 | 90000.0 | 7092.0 | 29254.0 | 24669.0 |
2023-09 | 2324.0 | 10584.0 | 2324.0 | 16304.0 | 19371.0 | 1115.0 | 39114.0 | 20547.0 | 412.0 | 10081.0 | 10493.0 | 3.0 | 475.0 | 15175.0 | 46218.0 | 0.0 | 85332.0 | 5672.0 | 17024.0 | 484.0 | 0.0 | 6591.0 | 29771.0 | 11924.0 | 0.0 | 0.0 | 2461.0 | 14385.0 | 0.0 | 3755.0 | 44156.0 | 0.0 | 3799.0 | 29082.0 | 0.0 | 8291.0 | 41172.0 | 41174.0 | 85332.0 | 2.0 | 85332.0 | 10587.0 | 28948.0 | 26624.0 |
2022-09 | 3546.0 | 0.0 | 3546.0 | 12527.0 | 15823.0 | 2831.0 | 34727.0 | 18762.0 | 691.0 | 9713.0 | 10404.0 | 7339.0 | 1432.0 | 2870.0 | 40807.0 | 4.0 | 75538.0 | 6249.0 | 11117.0 | 444.0 | 0.0 | 6165.0 | 23975.0 | 13452.0 | -437.0 | 437.0 | 2308.0 | 15760.0 | 0.0 | 2636.0 | 39735.0 | 0.0 | 3799.0 | 26546.0 | 1626.0 | 3830.0 | 35801.0 | 35803.0 | 75538.0 | 2.0 | 75538.0 | 7339.0 | 24569.0 | 21023.0 |
2021-09 | 10199.0 | -2705.0 | 10199.0 | 11866.0 | 12006.0 | 763.0 | 34834.0 | 14392.0 | 865.0 | 1532.0 | 2397.0 | 10467.0 | 1349.0 | 796.0 | 29401.0 | 4.0 | 64239.0 | 5713.0 | 9521.0 | 823.0 | 1824.0 | 2311.0 | 20192.0 | 9141.0 | -24.0 | 24.0 | 2226.0 | 11367.0 | 0.0 | 3189.0 | 31559.0 | 0.0 | 3799.0 | 24628.0 | 433.0 | 3819.0 | 32679.0 | 32680.0 | 64239.0 | 1.0 | 64239.0 | 7762.0 | 18662.0 | 8463.0 |
2020-09 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-09 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-09 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-09 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-09 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-09 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-09 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |

π Explore more balance sheet data for Fuji Pharma!
Sign up for free or log in
Have you heard about our short Daily Video Newsletter?
Find out more